JAK2 and myeloproliferative disorder: In some of these patients, a pathogenic, somatic variant in the Janus kinase 2 (JAK2) gene has been detected [13] and in one case CTEPH and the myeloproliferative disease was diagnosed in the same patient at the same time [11].